Given the prevalence of defects in the TP53 pathway in cancer, we chose to explore the role of Gata4 in tumorigenesis by deleting Gata4 in a p53-deficient genetically engineered mouse model (GEMM) of lung adenocarcinoma. Here, GATA4 is linked to lung adenocarcinoma.